Contrast optimization of fluid-attenuated inversion recovery (FLAIR) imaging

Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine
J N RydbergC R Jack

Abstract

The optimization of contrast is considered for the fluid-attenuated inversion recovery (FLAIR) MRI pulse sequence, specifically the contrast of multiple sclerosis (MS) to white matter (WM). A performance bound is identified at 1.5 Tesla as that provided using an inversion time (TI) of 2900 ms. It is shown that TR/TI times exceeding 11000/2600 ms provide about 90% of the MS-WM contrast possible theoretically. The commonly reported TR/TI combination of 6000/2000 provides only about 60%. For TR times exceeding 8000 ms, an echo time (TE) of 140 ms is at or near optimum. Use of TR/TI times less than 9000/2400 lacks efficiency in multisection imaging. Predicted relative contrast performance of TR/TI 11000/2600 versus 6000/2000 was evaluated in seven patients with known MS lesions, and measurements closely matched theoretical predictions. It is strongly recommended that for near optimum contrast and high multisection efficiency, FLAIR should be performed with TR/TI times exceeding 10000/2500 ms.

References

Nov 1, 1992·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·S J WhiteG M Bydder
Nov 1, 1992·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·R T Constable, J C Gore
Jul 1, 1992·Journal of Computer Assisted Tomography·J V HajnalG M Bydder
Jan 1, 1990·Magnetic Resonance Imaging·R V MulkernF A Jolesz
Sep 1, 1989·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·D H MillerW I McDonald
Sep 1, 1989·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·H B LarssonJ Olesen
Mar 1, 1988·Magnetic Resonance Imaging·J R MacFallR M Vavrek
May 1, 1988·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·H B LarssonJ Olesen
Oct 1, 1986·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·R K BregerV M Haughton
Dec 1, 1986·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·J HennigH Friedburg
Dec 1, 1985·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·H W ParkZ H Cho
Feb 1, 1986·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·J N Lee, S J Riederer
Nov 1, 1982·Medical Physics·R L Dixon, K E Ekstrand
Jun 1, 1984·Journal of Computer Assisted Tomography·F W WehrliR J Herfkens
Jun 1, 1983·Journal of Computer Assisted Tomography·W A EdelsteinL S Smith
Sep 1, 1994·Journal of Magnetic Resonance Imaging : JMRI·R G SteenJ S Taylor
Nov 1, 1993·Journal of Magnetic Resonance Imaging : JMRI·D G Mitchell, S W Atlas

❮ Previous
Next ❯

Citations

May 17, 2000·Journal of Magnetic Resonance Imaging : JMRI·M EssigG van Kaick
May 9, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M Essig, M Bock
Dec 18, 2001·Journal of Magnetic Resonance Imaging : JMRI·C R JackB J Erickson
Aug 14, 1998·Journal of Magnetic Resonance Imaging : JMRI·M EssigG van Kaick
Aug 1, 1996·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·J ListerudR Grossman
Jun 11, 1998·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·B J Bedell, P A Narayana
Dec 21, 2005·European Radiology·Rainald BachmannStefan Krämer
Feb 1, 1997·Surgical Neurology·E F JacksonN E Leeds
Feb 22, 2003·European Journal of Radiology·Tae-Ick ChungDong-Won Yang
Nov 12, 1998·Magnetic Resonance Imaging·G J Barker
Oct 24, 2003·The American Journal of Emergency Medicine·Sung Pil ChungGun Lee
Apr 18, 1998·The Laryngoscope·P ChangJ Roche
Apr 3, 2008·Current Opinion in Psychiatry·Perminder SachdevWei Wen
Oct 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·U C WieshmannJ M Stevens
Dec 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·M FilippiR Voltz
Dec 11, 2008·Neuroimaging Clinics of North America·Anthony Traboulsee, David K B Li
May 28, 2008·Journal of Magnetic Resonance Imaging : JMRI·Thomas C LauensteinDiego R Martin
Mar 26, 2013·Journal of Magnetic Resonance Imaging : JMRI·Bernd André Jung, Matthias Weigel
Dec 6, 2011·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Paul PolakGuy Poloni
May 19, 2011·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Ananth J MadhuranthakamDavid C Alsop
Sep 4, 2013·NMR in Biomedicine·Hoonjae LeeJaeseok Park
May 13, 2008·Biological Psychiatry·Ki Woong KimMartha E Payne
Apr 7, 1998·Clinical Radiology·G M BydderI R Young
Feb 11, 2004·Magnetic Resonance Imaging Clinics of North America·Zoran Rumboldt, Miljenko Marotti
Jan 22, 2005·Neurologic Clinics·Anthony TraboulseeDavid K B Li
Jul 1, 2014·Journal of Magnetic Resonance Imaging : JMRI·Neville D Gai, John A Butman
Jul 1, 2014·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Thomas BenkertFelix A Breuer
Dec 19, 2013·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Katharina FuchsThoralf Niendorf
Jul 22, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackMichael Weiner
Sep 3, 2013·Magnetic Resonance Imaging·Miho KitaHajime Tanaka
Jul 29, 2016·Journal of Medical Imaging and Radiation Oncology·Rayan Bou FakhredinFadi El-Merhi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.